Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 as treatment for Long Term COVID-19
2020-005961-16Phase 2Completed
- Sponsor
- Lars Jørgen Østergaard
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of coenzyme q10 in post-COVID syndrome, sponsored by Lars Jørgen Østergaard. Primary endpoint: Change in number and severity of self-reported long-term COVID-19 symptoms at 6 weeks. Started Dec 2020; status: completed.
02
Drugs
coenzyme q10
03
Conditions
post-COVID syndrome
Beyond the preview
Go deeper on 2020-005961-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005961-16.